Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $2.34 Analyst target: $12.25 Upside: 423.50%
CytomX Therapeutics, Inc. is an oncology-focused biopharmaceutical company in the United States. The company is headquartered in South San Francisco, California.
See the full interactive analysis & chart →Informational only — not investment advice.